{
    "nctId": "NCT00794989",
    "briefTitle": "Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer",
    "officialTitle": "A Study Evaluating the Effect of Flaxseed on Biomarkers of Breast Cancer Risk",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer, Precancerous Condition",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Alteration in intermediate biomarkers of breast cancer risk at baseline and at 1, 3, and 6 months",
    "eligibilityCriteria": "* Patients enrolled in must meet \u2265 1 of the following criteria:\n\n  * History of unilateral or bilateral atypical ductal hyperplasia with or without family history\n  * History of atypical lobular hyperplasia or lobular carcinoma in situ with or without family history\n  * History of ductal carcinoma in situ\n  * Prior stage I breast cancer allowed provided it was adequately treated and therapy was completed \u2265 1 year ago\n  * Lifetime risk for developing breast cancer \\> 20% (based on Gail or Claus model)\n  * No abnormal mammogram requiring short-term follow-up within the past 6 months\n  * No severe atypia or carcinoma cells on RPRNA\n\nPATIENT CHARACTERISTICS:\n\n* Premenopausal\n* ECOG performance status 0-1\n* Patients enrolled must meet the following criteria:\n\n  * No peri- or postmenopausal status as determined by estradiol levels \\< 20 ng/dL and FSH levels \\> 45 ng/dL\n  * No thrombocytopenia (defined as platelet count \\< 50,000/mm\\^3)\n  * Creatinine \u2264 1.5 mg/dL\n  * Not pregnant or nursing\n  * Fertile patients must use effective contraception consistently\n  * No other prior malignancy allowed except for the following:\n\n    * Basal cell or squamous cell carcinoma\n    * In situ cervical cancer\n  * No history of any of the following conditions within the past 5 years:\n\n    * Crohn disease\n    * Ulcerative colitis\n    * Inflammatory bowel disease\n    * Irritable bowel syndrome\n    * Celiac sprue\n    * Malabsorption syndrome\n    * Diverticulitis\n    * Diverticulosis\n  * No allergy to flaxseed, other seeds or nuts, or wheat\n\nPRIOR CONCURRENT THERAPY:\n\n* Patients enrolled in part 1 must meet the following criteria:\n\n  * No prior breast implants or tram-flap reconstruction\n\n    * Breast reduction allowed\n  * No prior neoadjuvant chemotherapy or other chemotherapy within the past year\n  * No prior neoadjuvant hormonal therapy\n  * No prior whole radiation to the contralateral breast undergoing random periareolar fine needle aspiration (RPFNA)\n  * No concurrent coumadin or other chronic anticoagulants (even if they are held for surgery)\n* Patients enrolled in part 2 must meet the following criteria:\n\n  * More than 1 year since prior chemotherapy and adjuvant hormonal therapy for breast cancer\n\n    * No concurrent chemotherapy for breast cancer\n  * At least 1 month since prior and no concurrent treatment with corticosteroid\n  * At least 2 weeks since prior and no concurrent use of antibiotics\n  * At least 2 weeks\n  * No history of chest wall irradiation\n  * No presence of breast implants\n  * No prior or concurrent tamoxifen within the past 90 days\n  * No chronic/concurrent medications that inhibit platelet function, including any of the following:\n\n    * Aspirin\n    * Non-steroidal anti-inflammatory drugs (i.e., Aleve\u00ae, Motrin\u00ae, ibuprofen)\n    * Coumadin\n    * Heparin\n    * Low molecular weight heparin\n    * Anti-platelet agents\n\n      * No prior short-term use of platelet inhibitors \u2265 7 days prior to RPFNA\n  * No concurrent ingestion of the following:\n\n    * Pumpkin seeds\n    * Sesame seeds\n    * Fish oil supplements\n  * At least 30 days since prior and no concurrent flaxseed supplements, fish oil, or flaxseed oil\n  * No concurrent treatment for another malignancy",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT"
}